Thyroid dysfunction and cardiovascular diseases: problem and ways to solve it

Main Article Content

V.Z. Netyazhenko
A.V. Liakhotska


Thyroid diseases are widespread and are the most common endocrine pathology, especially in regions with iodine deficiency in the environment. Thyroid dysfunction is diagnosed in 5–10 % of the population, more often in women and in the age group over 60 years. With increasing age, the occurrence of comorbid diseases in patients is increasing significantly. Among them, the first place belongs to the pathology of the cardiovascular system. One of the factors is endothelial dysfunction, which is one of the predictors of morphological changes in the vascular wall in many chronic diseases, in particular, atherosclerosis, arterial hypertension, thyroid diseases, and others.

Article Details

How to Cite
Netyazhenko, V., and A. Liakhotska. “Thyroid Dysfunction and Cardiovascular Diseases: Problem and Ways to Solve It”. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), vol. 16, no. 4, May 2020, pp. 333-6, doi:10.22141/2224-0721.16.4.2020.208487.
To practicing Endocrinologists


Center for Medical Statistics. Indicators of public health and use of health care resources in Ukraine for 2017. 2017. (in Ukrainian). Available from:

Center for Medical Statistics Indicators of hospital morbidity in Ukraine for 2018. 2018. (In Ukrainian). Available from:

Rugge JB, Bougatsos C, Chou R. Screening and treatment of thyroid dysfunction: an evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2015;162(1):35-45. doi:10.7326/M14-1456.

Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304(12):1365-1374. doi:10.1001/jama.2010.1361.

Biondi B, Bartalena L, Cooper DS, Hegedüs L, Laurberg P, Kahaly GJ. The 2015 European Thyroid Association Guidelines on Diagnosis and Treatment of Endogenous Subclinical Hyperthyroidism. Eur Thyroid J. 2015;4(3):149-163. doi:10.1159/000438750.

Udovcic M, Pena RH, Patham B, Tabatabai L, Kansara A. Hypothyroidism and the Heart. Methodist Debakey Cardiovasc J. 2017;13(2):55-59. doi:10.14797/mdcj-13-2-55.

Pankiv VI, Yuzvenko TYu, Pankiv IV. Type 2 diabetes mellitus and subclinical hypothyroidism: focusing on the role of cholecalciferol. Problemi endokrinnoi patologii. 2019;(2):46-51. doi:10.21856/j-PEP.2019.2.07.

Jabbar A, Pingitore A, Pearce SH, Zaman A, Iervasi G, Razvi S. Thyroid hormones and cardiovascular disease. Nat Rev Cardiol. 2017;14(1):39-55. doi:10.1038/nrcardio.2016.174.

Asvold BO, Vatten LJ, Nilsen TI, Bjøro T. The association between TSH within the reference range and serum lipid concentrations in a population-based study. The HUNT Study. Eur J Endocrinol. 2007;156(2):181-186. doi:10.1530/eje.1.02333.

Pingitore A, Landi P, Taddei MC, Ripoli A, L'Abbate A, Iervasi G. Triiodothyronine levels for risk stratification of patients with chronic heart failure. Am J Med. 2005;118(2):132-136. doi:10.1016/j.amjmed.2004.07.052.

Rodondi N, Bauer DC, Cappola AR, et al. Subclinical thyroid dysfunction, cardiac function, and the risk of heart failure. The Cardiovascular Health study. J Am Coll Cardiol. 2008;52(14):1152-1159. doi:10.1016/j.jacc.2008.07.009.

Floriani C, Gencer B, Collet TH, Rodondi N. Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update. Eur Heart J. 2018;39(7):503-507. doi:10.1093/eurheartj/ehx050.

Knuuti J, Wijns W, Saraste A, at al. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes: The Task Force for the diagnosis and management of chronic coronary syndromes of the European Society of Cardiology. European Heart Journal. 2020;41(3):407-477. doi:10.1093/eurheartj/ehz425.

Pashkovska NV. Pseudothyroid dysfunction in clinical practice: how to avoid diagnostic errors. Mìžnarodnij endokrinologìčnij žurnal. 2018;14(4):344-353. doi:10.22141/2224-0721.14.4.2018.140188. (in Ukrainian).

Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891-975. doi:10.1002/ejhf.592.